sTREM2

Biomarker

7 papers12 findings

  • Humans7

Effects

2

Aβ-PET centiloid

mediatesin humans1downin humans1

1 study
  1. sTREM2 mediates Aβ-PET centiloid in humans (attenuation by 27%).

    “attenuating the relationship between p ‐tau 231 and Aβ‐PET accumulation by 27%”

    Humansmediates association between p-tau231 and Aβ-PET accumulationbrain

    Microglial reactivity attenuates ptau ₂₃₁ ‐related amyloid accumulation in preclinical Alzheimer’s disease

    AAIC 2025 abstractDec 23, 2025

  2. sTREM2 decreases Aβ-PET centiloid in humans (β -1.67 (95% CI -2.83 to -0.51), p < 0.01).

    “Notably, higher sTREM2 was associated with reduced rates of Aβ accumulation (β [95% CI]: ‐1.67 [‐2.83 to ‐0.51], p <0.01)”

    Humansbrain

    Microglial reactivity attenuates ptau ₂₃₁ ‐related amyloid accumulation in preclinical Alzheimer’s disease

    AAIC 2025 abstractDec 23, 2025

More on Aβ-PET centiloid

Cognitive function

mediatesin humans1

1 study
  1. sTREM2 mediates cognitive function in humans.

    “CSF sTREM2 fully mediated the link between older brain-age and cognitive decline in ALFA+”

    Humansin ALFA+ cohort

    Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers

    Molecular psychiatryApr 12, 2025

Upstream

1

P-TAU231

upin humans1

1 study
  1. P-TAU231 increases sTREM2 in humans (β 0.18 (95% CI 0.11–0.25), p < 0.001).

    “Elevated p ‐tau 231 was also linked to increased CSF sTREM2 (β [95% CI]: 0.18 [0.11–0.25], p <0.001).”

    Humansbrain

    Microglial reactivity attenuates ptau ₂₃₁ ‐related amyloid accumulation in preclinical Alzheimer’s disease

    AAIC 2025 abstractDec 23, 2025

More on P-TAU231

Associations

7

Neurogranin

downin humans1

1 study
  1. sTREM2 is associated with neurogranin in humans (β = -0.01, p = 0.03 for WRAP; β = -0.01, p = 0.04 in ALFA+).

    “higher baseline sTREM2 was associated with a smaller longitudinal increase in neurogranin in both cohorts (β = -0.01, p = 0.03 for WRAP, β = -0.01, p = 0.04 in ALFA+)”

    Humanscerebrospinal fluid

    Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

    Molecular neurodegenerationOct 17, 2025

  2. Neurogranin predicts sTREM2 in humans (β = -0.02, p = 0.006).

    “lower baseline neurogranin and α-synuclein and higher S100B predicted greater increases in sTREM2 over time independently of AD-related markers in the WRAP cohort (β = -0.02, p = 0.006”

    Humanscerebrospinal fluid

    Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

    Molecular neurodegenerationOct 17, 2025

More on Neurogranin

Aβ accumulation

downin humans1

1 study
  1. sTREM2 is associated with Aβ accumulation in humans (β -1.67, 95% CI -2.83 to -0.51, p<0.01).

    “higher sTREM2 was associated with reduced rates of Aβ accumulation (β [95% CI]: ‐1.67 [‐2.83 to ‐0.51], p <0.01)”

    Humanscognitively unimpaired individuals3.4 yearsn = 187

    Microglial reactivity attenuates ptau ₂₃₁ ‐related amyloid accumulation in preclinical Alzheimer's disease

    AAIC 2025 abstractDec 24, 2025

P-TAU231

upin humans1

1 study
  1. P-TAU231 is associated with sTREM2 in humans (β 0.18, 95% CI 0.11–0.25, p<0.001).

    “Elevated p ‐tau 231 was also linked to increased CSF sTREM2 (β [95% CI]: 0.18 [0.11–0.25], p <0.001).”

    Humanscognitively unimpaired individuals3.4 yearsn = 187

    Microglial reactivity attenuates ptau ₂₃₁ ‐related amyloid accumulation in preclinical Alzheimer's disease

    AAIC 2025 abstractDec 24, 2025

More on P-TAU231

S100B

upin humans1

1 study
  1. S100B predicts sTREM2 in humans (β = 0.02, p = 0.03).

    “higher S100B predicted greater increases in sTREM2 over time independently of AD-related markers in the WRAP cohort (β = -0.02, p = 0.006; β = -0.02, p = 0.01; β = 0.02, p = 0.03”

    Humanscerebrospinal fluid

    Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

    Molecular neurodegenerationOct 17, 2025

More on S100B

α-synuclein

downin humans1

1 study
  1. α-synuclein predicts sTREM2 in humans (β = -0.02, p = 0.01).

    “α-synuclein and higher S100B predicted greater increases in sTREM2 over time independently of AD-related markers in the WRAP cohort (β = -0.02, p = 0.006; β = -0.02, p = 0.01”

    Humanscerebrospinal fluid

    Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

    Molecular neurodegenerationOct 17, 2025

More on α-synuclein

Brain age delta

downin humans1

1 study
  1. sTREM2 is associated with brain age delta in humans.

    “higher CSF sTREM2 was associated with a younger brain-age after adjusting for AD pathology”

    Humansadjusted for AD pathology

    Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers

    Molecular psychiatryApr 12, 2025

More on Brain age delta

Female sex

upin humans1

1 study
  1. Female sex is associated with sTREM2 in humans (β = 0.146, P = 0.002).

    “among the APOE ε4 allele carriers, women exhibited significantly higher sTREM2 levels than men (β = 0.146, P = 0.002).”

    Humansin APOE ε4 allele carrierscerebrospinal fluid

    The longitudinal trajectory of CSF sTREM2: the alzheimer's disease neuroimaging initiative

    Alzheimer's research & therapyJun 26, 2024

Latest

Nov 2025: 0Dec 2025: 3Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 04 in 12 months